Since August 2025, this page features a monthly selection of recent scientific publications from around the world related to bacteriocins. Each update highlights key discoveries and advances in the field, providing a concise overview of emerging research trends. The aim is to offer an accessible and regularly updated window into the rapidly evolving world of bacteriocin science. Enjoy reading!
May 2026
𧬠Implantable living materials turn engineered bacteria into autonomous depots for local antimicrobial delivery.
This study develops a tough implantable hydrogel that physically contains engineered bacteria for months while allowing them to sense infection signals and release therapeutic proteins on demand. The therapeutic payload is a pyocin-derived antibacterial protein, illustrating how bacteriocin-like molecules can be produced in situ and locally delivered to reduce Pseudomonas aeruginosa infection in a prosthetic joint model.
π Read the paper
𧬠The Hungate1000 collection reveals the rumen as a major reservoir of hidden bacteriocin diversity.
This in silico study mined 410 cultured rumen prokaryotes and identified 408 novel bacteriocin gene clusters across 308 genomes, including new nisin variants, circular bacteriocins, lassopeptides, and lanthipeptides. It shows that bacteriocin biosynthetic potential in rumen isolates may be far more widespread than previously appreciated, positioning the rumen microbiome as a rich source of new bacteriocins for microbiome modulation, livestock applications, and antimicrobial discovery.
π Read the paper
𧬠Pediocin-like bacteriocins emerge as promising computational candidates against Candida albicans virulence.
This study explores whether bacteriocins, specifically pediocin-like peptides, could be repurposed as antifungal agents by targeting SAP2, a key secreted protease involved in C. albicans pathogenicity. The authors identify Coagulin A and Pediocin PA-1 as the most promising bacteriocin candidates, supporting the idea that bacteriocins may extend beyond antibacterial use into antifungal targeting strategies.
π Read the paper
𧬠An engineered bacteriocin gives peppers a new line of defense against soft rot.
This study describes paracin wx7-1, an engineered bacteriocin with strongly improved activity against Pectobacterium carotovorum, the Gram-negative pathogen responsible for pepper soft rot. Beyond directly damaging bacterial membranes and suppressing core metabolic and virulence pathways, this bacteriocin also primes pepper defense responses, highlighting a dual-action strategy for postharvest disease control and preservation.
π Read the paper
April 2026
𧬠A new unified framework aims to bring clarity to the expanding world of bacteriocins.
This review proposes an updated classification scheme for bacteriocins from gram-positive bacteria, with a strong focus on Lactobacillaceae, and introduces a standardized source-based nomenclature to improve consistency across the field. By systematically compiling 474 bacteriocins reported in Lactobacillaceae, it also shows that most remain only partially characterized, highlighting both the scale of known diversity and the urgent need for deeper functional and genomic validation.
π Read the paper
𧬠Engineered bacteriocin-derived probes enable targeted manipulation of specific bacteria within mixed microbial systems.
This study uses the class IIa bacteriocin pediocin PA-1 as a model to show that bacteriocins can do more than kill: they can also be redesigned as selective molecular probes to manipulate defined bacterial subpopulations. By combining native and modified pediocin variants, the authors demonstrate both targeted depletion and non-bactericidal tagging of closely related species within synthetic communities, highlighting bacteriocins as promising precision tools to study and engineer microbial ecosystems.
π Read the paper
𧬠A bacteriocin-producing commensal can stably integrate into the oral microbiome and selectively suppress pathogens.
This study shows that Streptococcus salivarius strains producing phosphorylated lantibiotics (pLANs) can engraft into oral microbial communities, inhibit periodontal and respiratory pathogens, and support microbiome homeostasis while sparing beneficial bacteria. The authors position bacteriocin-producing commensals as a precision strategy to reduce pathogen burden, antibiotic-resistance signals, and inflammatory markers in the oral cavity.
π Read the paper
𧬠A bacteriocin gene helps Bifidobacterium breve adapt and persist in the adult human gut.
This study shows that the type III lanthipeptide bacteriocin gene cluster lanKC, found in specific adult-derived B. breve strains, enhances competitive fitness and helps stabilize gut microbial community structure. Rather than being explained only by carbohydrate utilization, the persistence of these strains appears to also rely on bacteriocins that selectively inhibit competing species, revealing a complementary ecological mechanism for long-term colonization. Phylogenetic and metagenomic analyses further suggest that this bacteriocin locus may have been acquired early in life through intra-genus horizontal transfer.
π Read the paper
𧬠S. mitis bacteriocins can selectively lyse pneumococci and accelerate gene exchange in biofilms.
This study identifies a diverse family of competence-associated bacteriocins in Streptococcus mitis and shows that one pair, CabAB, drives contact-dependent lysis of S. pneumoniae during competence. By promoting DNA release from neighboring pneumococci in multispecies biofilms, these bacteriocins enhance horizontal gene transfer from S. pneumoniae to S. mitis, highlighting bacteriocins as key ecological factors shaping streptococcal adaptation and evolution.
π Read the paper
𧬠A new circular bacteriocin shows strong promise against Bacillus cereus, its biofilms, and its spores in food systems.
This study identifies toyoncin WJY28, a novel circular bacteriocin produced by Bacillus toyonensis, with potent and selective anti-B. cereus activity that also suppresses biofilm formation, kills cells within mature biofilms, and blocks spore outgrowth.
π Read the paper
𧬠A newly discovered bacteriocin from a Liquorilactobacillus strain expands the diversity of non-pediocin-like Class IId peptides.
This study identifies lactobacin A, a novel single-peptide bacteriocin produced by a Liquorilactobacillus strain. It shows that this bacteriocin is structurally distinct from known pediocin-like peptides, with its N-terminal region being critical for activity, and that it remains highly stable across broad pH, heat, and oxidative conditions, highlighting new bacteriocin diversity with potential value for antimicrobial and food applications.
π Read the paper
𧬠A new saposin-like leaderless bacteriocin broadens the antimicrobial potential of Staphylococcus–derived peptides.
This study identifies saprophyticin S, a novel bacteriocin produced by Staphylococcus saprophyticus, and shows that this highly cationic leaderless peptide displays broad activity against Gram-positive pathogens of clinical, veterinary, and food relevance, including MRSA and VRE. The authors further show that this bacteriocin shares key structural features with aureocin-like peptides and can act synergistically with Gram-negative bacteriocins against Escherichia coli, highlighting new opportunities to expand bacteriocin-based antimicrobial strategies.
π Read the paper
𧬠High-copy plasmid engineering gives Corynebacterium glutamicum a major boost for bacteriocin production.
This study shows that rational redesign of a pCG1-family plasmid can strongly increase gene dosage and expression capacity in C. glutamicum, creating a more powerful platform for recombinant antimicrobial peptide production. Applied to the bacteriocin pediocin PA-1, the best high-copy variant increased titers about 2.5-fold over the previous reference system under identical conditions, highlighting plasmid engineering as a practical route to make bacteriocin manufacturing more efficient and scalable.
π Read the paper
𧬠A yeast expression platform delivers strong recombinant production of the bacteriocin enterocin A.
This study shows that Saccharomyces cerevisiae can efficiently produce recombinant enterocin A, highlighting yeast as a promising platform for scalable bacteriocin production and for studying how disulphide bond formation shapes bacteriocin activity.
π Read the paper
𧬠A smart hydrogel turns the bacteriocin bifidocin A into a pH-triggered preservation system for salmon.
This study develops a gelatin-based hydrogel that covalently incorporates the bacteriocin bifidocin A and releases it in response to pH changes associated with spoilage. The material combines sustained bacteriocin delivery, antibacterial activity, and antioxidant protection, and in chilled salmon it preserved microbiological, physicochemical, and sensory quality far better than the controls.
π Read the paper
March 2026
𧬠An engineered yeast turns bacteriocins into an antibiotic-free tool to protect industrial ethanol fermentations.
This study shows that an amylolytic Saccharomyces cerevisiae strain engineered to co-produce the bacteriocin mundticin ST4SA can strongly suppress lactic acid bacterial contaminants during raw starch-to-ethanol fermentation. By combining starch hydrolysis, ethanol production, and bacteriocin-mediated microbial control in a single yeast platform, the authors demonstrate a practical strategy to reduce contamination and improve ethanol yields without relying on antibiotics.
π Read the paper
𧬠Bacteriocins can help preserve colistin efficacy against multidrug-resistant Acinetobacter baumannii.
This study shows that combining low concentrations of bacteriocins with colistin strongly reduces the survival of multidrug-resistant A. baumannii, limits the emergence of colistin-resistant mutants, and can partially restore susceptibility in resistant strains. By exploiting the membrane-disrupting activity of colistin, the bacteriocins gain access to their target and reinforce envelope damage, highlighting bacteriocin-antibiotic combinations as a promising strategy against highly drug-resistant Gram-negative pathogens.
π Read the paper
February 2026
𧬠Two 
newly identified class IId bacteriocins expand the antimicrobial potential of L. petauri.
This study identifies petauricin A and petauricin B, two novel bacteriocins produced by Lactococcus petauri NC2, marking the first such report for this species. While petauricin A shows narrow activity against L. garvieae, petauricin B displays a broader spectrum across several Gram-positive genera, and both peptides act in a bactericidal manner. Together, these findings highlight new bacteriocin scaffolds with potential value for food biopreservation and for controlling L. garvieae and L. petauri in aquatic settings.
π Read the paper
𧬠An oral probiotic packs an exceptional bacteriocin arsenal for targeted microbial control.
This study shows that Streptococcus dentisani 7746 encodes and transcriptionally expresses a remarkable cocktail of 14 bacteriocins, making it one of the richest bacteriocin repertoires described so far. The authors also identify complete Com- and Blp-like quorum sensing systems linked to this antimicrobial arsenal, providing a regulatory framework for how bacteriocin production may support oral health and enable future bacteriocin cocktail design against oral pathogens.
π Read the paper
January 2026
𧬠Bacteriocin-inspired βmicrobial shippingβ turns probiotics into precision peptide couriers for gut healing.
Inspired by how bacteria naturally transport and deploy bacteriocins, this study engineers an oral βall-in-oneβ platform that co-delivers the LL37 peptide with Lactobacillus, protecting the payload through digestion and releasing it where it matters in the gut. In multiple mouse models of colitis, the system helps restore gut homeostasis.
π Read the paper
𧬠A food-grade bacteriocin is transformed into carrier-free nanoparticles for stronger, broader antimicrobial action.
This study engineers a lactic-acid-bacteria bacteriocin from fermented food to self-assemble into nano-bacteriocins without any external carrier, improving solubility and functional stability while expanding activity against both Gram-positive and Gram-negative pathogens. The resulting nanoparticles show enhanced in vitro potency and strong therapeutic efficacy in infected mice, with mechanistic analyses pointing to targeted disruption and remodeling of bacterial cell envelopes.
π Read the paper
𧬠A detailed map of how the bacteriocin Microcin Y enters bacteria, guiding smarter antimicrobial design.
This study dissects the uptake route of the lasso bacteriocin Microcin Y (MccY) in Salmonella Typhimurium, showing how the outer-membrane receptor FhuA and inner-membrane transporter SbmA govern recognition, transport, and susceptibility. By combining structural docking, targeted receptor mutations, and transcriptomics, the authors pinpoint key interaction hotspots and the adaptive gene-expression programs associated with reduced MccY uptake. Overall, it provides a practical framework to engineer and deploy bacteriocins with improved entry efficiency and sustained activity.
π Read the paper
December 2025
𧬠A newly discovered bacteriocin shows strong activity against multidrug-resistant Escherichia coli.
This study reports PFS-3, a novel bacteriocin produced by Bacillus velezensis FS-3, and shows that this small, highly stable bacteriocin can inhibit a broad range of bacteria, with particularly strong activity against Gram-negative strains. The authors link its antibacterial effect to disruption of cardiolipin-rich membranes and report low toxicity alongside protective efficacy in infection models, supporting bacteriocins as promising alternatives to conventional antimicrobials.
π Read the paper
π Nisin can boost antibiotic efficacy and help disrupt Staphylococcus aureus biofilms.
This study shows that combining sub-inhibitory nisin with the veterinary antibiotic ceftiofur significantly reduces the growth of antibiotic-resistant S. aureus strains associated with bovine mastitis. The same combination also displays antibiofilm activity, limiting biofilm formation and reducing viable cells within established biofilms, highlighting how bacteriocins can serve as practical antibiotic enhancers.
π Read the paper
November 2025
π± Bacteriocin-driven competition enables precise and predictable microbiome remodeling.
This study demonstrates that strain displacement in complex microbiomes can be achieved through natural ecological competition, with bacteriocins playing a central role as selective antagonistic factors. By combining experimental data and ecological modeling, the authors show how bacteriocin-mediated interactions allow targeted replacement of specific strains while maintaining overall community stability. The work highlights bacteriocins as powerful and tunable tools for microbiome engineering based on ecological principles rather than broad-spectrum disruption.
π Read the paper
𧬠The human gut harbors a vast, largely untapped arsenal of class II bacteriocins.
This Preview article summarizes and contextualizes recent large-scale work describing a genomics-guided atlas of unmodified class II bacteriocins encoded by the human gut microbiome. It highlights how thousands of previously unknown bacteriocins can be identified, prioritized using meta-omics data, and validated experimentally, emphasizing their narrow-spectrum activity and microbiome-sparing potential.
π Read the paper
𧬠A practical engineering roadmap to turn bacteriocins into stable, health-modulating postbiotics.
This review lays out an integrated approach to designing postbiotic products, covering strain selection, inactivation strategies, formulation, and quality control to preserve bioactivity. It highlights bacteriocins as robust, process-tolerant antimicrobial components that can deliver targeted activity and help shape microbial ecosystems in a controlled, microbiome-friendly way.
π Read the paper
October 2025
π¦ A newly identified bacteriocin from Bacillus velezensis reshapes gut microbiota.
Researchers isolated and characterized a bacteriocin, PG02, produced by Bacillus velezensis G02. The purified peptide (20β31 kDa) showed strong activity against both Gram-positive and Gram-negative bacteria and remained stable after exposure to digestive enzymes. In vivo experiments in mice revealed no organ toxicity but a significant modulation of intestinal microbiota, reducing harmful species while enriching beneficial Lactobacillus populations.
π Read the paper
𧫠Cryo-EM reveals how Microcin V precisely recognizes and enters target bacteria.
This study provides a high-resolution structure of Microcin V bound to its receptor Cir, a TonB-dependent transporter in E. coli. Using cryo-electron microscopy, the authors identified an electropositive pocket on Cir that anchors Microcin V with nanomolar affinity, an interaction essential for import and activity. These findings offer valuable structural insights into how microcins exploit natural transport pathways, opening new opportunities for engineering next-generation antibacterial peptides.
π Read the paper
𧬠Bacteriocins shape microbial interactions and highlight the genetic versatility of E. coli
This large-scale genomic study of more than 2,600 E. coli strains reveals the remarkable diversity, mobility, and ecological importance of bacteriocin systems. These peptides frequently coexist with genes involved in nutrient acquisition and microbial competition, illustrating how bacterial genomes integrate multiple adaptive traits to thrive in complex environments.
π Read the paper
September 2025
𧫠A global exploration reveals the hidden bacteriocin potential of the human gut microbiome.
This study presents IIBacFinder, a new computational tool that systematically detects unmodified class II bacteriocins across bacterial genomes. By analyzing over 280,000 human gut genomes and validating synthetic candidates experimentally, the authors uncover a vast diversity of narrow-spectrum bacteriocins with minimal disruption to gut microbiota, highlighting their potential role in health and antimicrobial discovery.
π Read the paper
August 2025
𧬠A fast-track platform to design bacteriocin cocktails against resistant pathogens.
This work demonstrates a rapid cell-free platform to generate and test bacteriocin cocktails, including circular and linear forms, directly against resistant pathogens. It shows how engineered combinations can both eliminate bacteria and limit resistance development.
π ReadΒ the paper
π‘οΈ A new peptide class builds permanent pores to kill bacteria more effectively.
A new antimicrobial peptide class (TMcins) was identified, forming stable Ξ²-barrel pores anchored by transmembrane helices. These pores provide durable antimicrobial activity and represent a new structural mechanism of action.
π Read the paper
πΏ The human gut hides a powerful new bacteriocin: mediterrocin.
Researchers discovered βmediterrocin,β a broad-spectrum bacteriocin from the gut bacterium Mediterraneibacter gnavus. It inhibits both commensal Lachnospiraceae and the pathogen Morganella morganii, with implications for gut health and disease.
π Read the paper
π§ͺ The skin microbiome reveals active, previously unknown bacteriocins.
Metatranscriptomic analysis across human skin sites revealed active expression of diverse antimicrobial genes, including previously unknown bacteriocins. The study highlights the skin microbiome as a dynamic source of novel antimicrobial molecules.
π Read the paper
βοΈ Some probiotics worsen infection risk, others protect thanks to bacteriocins.
Different Lactobacillus strains were shown to modulate recovery from antibiotics in mice: L. acidophilus worsened C. difficile colonization, while L. gasseri restored resistance partly through bacteriocin production.
π Read the paper
You must be logged in to post a comment.